Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

406 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Teprotumumab Efficacy, Safety, and Durability in Longer-Duration Thyroid Eye Disease and Re-treatment: OPTIC-X Study.
Douglas RS, Kahaly GJ, Ugradar S, Elflein H, Ponto KA, Fowler BT, Dailey R, Harris GJ, Schiffman J, Tang R, Wester S, Jain AP, Marcocci C, Marinò M, Antonelli A, Eckstein A, Führer-Sakel D, Salvi M, Sile S, Francis-Sedlak M, Holt RJ, Smith TJ. Douglas RS, et al. Among authors: marcocci c. Ophthalmology. 2022 Apr;129(4):438-449. doi: 10.1016/j.ophtha.2021.10.017. Epub 2021 Oct 21. Ophthalmology. 2022. PMID: 34688699 Free article. Clinical Trial.
Current medical management of Graves ophthalmopathy.
Marcocci C, Bartalena L, Marinò M, Rocchi R, Mazzi B, Menconi F, Morabito E, Pinchera A. Marcocci C, et al. Ophthalmic Plast Reconstr Surg. 2002 Nov;18(6):402-8. doi: 10.1097/00002341-200211000-00003. Ophthalmic Plast Reconstr Surg. 2002. PMID: 12439051 Review. No abstract available.
Multi-center study on the characteristics and treatment strategies of patients with Graves' orbitopathy: the first European Group on Graves' Orbitopathy experience.
Prummel MF, Bakker A, Wiersinga WM, Baldeschi L, Mourits MP, Kendall-Taylor P, Perros P, Neoh C, Dickinson AJ, Lazarus JH, Lane CM, Heufelder AE, Kahaly GJ, Pitz S, Orgiazzi J, Hullo A, Pinchera A, Marcocci C, Sartini MS, Rocchi R, Nardi M, Krassas GE, Halkias A. Prummel MF, et al. Among authors: marcocci c. Eur J Endocrinol. 2003 May;148(5):491-5. doi: 10.1530/eje.0.1480491. Eur J Endocrinol. 2003. PMID: 12720530
Preferential megalin-mediated transcytosis of low-hormonogenic thyroglobulin: a control mechanism for thyroid hormone release.
Lisi S, Pinchera A, McCluskey RT, Willnow TE, Refetoff S, Marcocci C, Vitti P, Menconi F, Grasso L, Luchetti F, Collins AB, Marino M. Lisi S, et al. Among authors: marcocci c. Proc Natl Acad Sci U S A. 2003 Dec 9;100(25):14858-63. doi: 10.1073/pnas.2432267100. Epub 2003 Dec 1. Proc Natl Acad Sci U S A. 2003. PMID: 14657389 Free PMC article.
Thyroid dysfunction in megalin deficient mice.
Lisi S, Segnani C, Mattii L, Botta R, Marcocci C, Dolfi A, McCluskey RT, Pinchera A, Bernardini N, Marinò M. Lisi S, et al. Among authors: marcocci c. Mol Cell Endocrinol. 2005 May 31;236(1-2):43-7. doi: 10.1016/j.mce.2005.03.009. Mol Cell Endocrinol. 2005. PMID: 15878230
Clinical features of dysthyroid optic neuropathy: a European Group on Graves' Orbitopathy (EUGOGO) survey.
McKeag D, Lane C, Lazarus JH, Baldeschi L, Boboridis K, Dickinson AJ, Hullo AI, Kahaly G, Krassas G, Marcocci C, Marinò M, Mourits MP, Nardi M, Neoh C, Orgiazzi J, Perros P, Pinchera A, Pitz S, Prummel MF, Sartini MS, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO). McKeag D, et al. Among authors: marcocci c. Br J Ophthalmol. 2007 Apr;91(4):455-8. doi: 10.1136/bjo.2006.094607. Epub 2006 Oct 11. Br J Ophthalmol. 2007. PMID: 17035276 Free PMC article.
A treatment strategy for Graves' orbitopathy.
Marcocci C, Pinchera A, Marinò M. Marcocci C, et al. Nat Clin Pract Endocrinol Metab. 2007 May;3(5):430-6. doi: 10.1038/ncpendmet0500. Nat Clin Pract Endocrinol Metab. 2007. PMID: 17452970
Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.
Bartalena L, Baldeschi L, Dickinson A, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits M, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas GE, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM; European Group on Graves' Orbitopathy (EUGOGO). Bartalena L, et al. Among authors: marcocci c. Eur J Endocrinol. 2008 Mar;158(3):273-85. doi: 10.1530/EJE-07-0666. Eur J Endocrinol. 2008. PMID: 18299459 No abstract available.
Consensus statement of the European group on Graves' orbitopathy (EUGOGO) on management of Graves' orbitopathy.
Bartalena L, Baldeschi L, Dickinson AJ, Eckstein A, Kendall-Taylor P, Marcocci C, Mourits MP, Perros P, Boboridis K, Boschi A, Currò N, Daumerie C, Kahaly GJ, Krassas G, Lane CM, Lazarus JH, Marinò M, Nardi M, Neoh C, Orgiazzi J, Pearce S, Pinchera A, Pitz S, Salvi M, Sivelli P, Stahl M, von Arx G, Wiersinga WM. Bartalena L, et al. Among authors: marcocci c. Thyroid. 2008 Mar;18(3):333-46. doi: 10.1089/thy.2007.0315. Thyroid. 2008. PMID: 18341379 No abstract available.
406 results